Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01594164
Other study ID # FLUI-2010-61
Secondary ID
Status Completed
Phase Phase 1
First received May 3, 2012
Last updated October 19, 2012
Start date March 2011
Est. completion date April 2011

Study information

Verified date October 2012
Source FLUIDDA nv
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

In this study the changes in upper airway geometry and resistance between images, obtained in upright and supine position, will be evaluated. Therefore a Cone Beam Computed Tomography (CBCT) scan and a low dose Computed Tomography (CT) scan will be taken in a population of 20 subjects. The upright morphology will be obtained using CBCT scan while the supine upper airway geometry will be determined using a standard High Resolution Computed Tomography (HRCT) scanner.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Written informed consent obtained.

- Male or female subject aged = 18 years.

- BMI < 25 kg/m2 (group 1), BMI = 25 kg/m2 and < 30 kg/m2 (group 2) and BMI = 30 kg/m2 (group 3) at visit 0. BMI calculation should be repeated if the interval visit 0 - visit 1 > 14 days.

- Female subject of childbearing potential who confirms that a contraception method was used at least two months before visit 1.

Exclusion Criteria:

- Subject is under the age of legal consent.

- Subject who is pregnant or is breast-feeding.

- Subject with a history of surgery of the upper airway.

- Subject with a history of any illness that, in opinion of the investigator, might confound the results of the study or poses an additional risk to the subject by participation in the study.

- Subject is unlikely to comply with the protocol or unable to understand the nature, scope and possible consequences of the study.

- Subject who received any investigational new drug within the last 4 weeks prior to visit 1.

- Subject who has claustrophobia.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Radiation:
Cone Beam Computed Tomography
CBCT scan of upper airway, in upright position.
High Resolution Computed Tomography
HRCT scan of upper airway, in supine position.

Locations

Country Name City State
Belgium Antwerp University Hospital Edegem Antwerp

Sponsors (1)

Lead Sponsor Collaborator
FLUIDDA nv

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in upper airway geometry The primary objective of this study is to compare the volume and resistance of the upper airway in supine versus upright position using High Resolution Computed Tomography (HRCT) and Cone Beam Computed Tomography (CBCT) images. At day 1 No
Secondary Body mass index (BMI) In addition the effect of elevated BMI on the changes in upper airway morphology will be assessed. At screening and also at day 1 (if interval screening - day 1 > 14 days) No